Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
| Brand name | DESIPRAMINE HYDROCHLORIDE |
| Generic name | DESIPRAMINE HYDROCHLORIDE |
| Active ingredient(s) | DESIPRAMINE HYDROCHLORIDE |
| Distributed by / for | Avet Pharmaceuticals Inc., East Brunswick, NJ 08816 |
| NDC | 23155-581-01 |
| Full product label | Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx only, Manufactured by: USV Private Limited, Daman, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816. |
| Recalling firm | Heritage Pharmaceuticals Inc |
| Distribution | U.S. Nationwide. |
| Quantity | 2,418 bottles. |
| Recall initiated | 2025-10-06 |
| Report date | 2025-11-05 |
| Recall completed | — |
| Recall number | D-0110-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | East Brunswick NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗